Article Dans Une Revue Acta Diabetologica Année : 2023

Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis

Résumé

To investigate the lowering BP effects of sodium glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) on the risk of major cardiovascular event stratified by glucose-lowering drugs, baseline BP, glycated hemoglobin (HbA1c), and history of cardiovascular disease in patients with type 2 diabetes.
Fichier non déposé

Dates et versions

hal-04878949 , version 1 (10-01-2025)

Identifiants

Citer

Alhassane Diallo, Miguel Carlos-Bolumbu, Florence Galtier. Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis. Acta Diabetologica, 2023, 60 (12), pp.1651-1662. ⟨10.1007/s00592-023-02154-4⟩. ⟨hal-04878949⟩

Collections

UNIV-MONTPELLIER
1 Consultations
0 Téléchargements

Altmetric

Partager

More